Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renalytix Ai Plc ADR (NQ: RNLX )

0.2071 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Renalytix Ai Plc ADR

< Previous 1 2 3 4 5 6 7 8 Next >
Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Renalytix to Present at Stifel Healthcare Conference
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Recap: Renalytix Q4 Earnings
Renalytix (NASDAQ:RNLX) reported its Q4 earnings results on Monday, October 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Renalytix Q3 Earnings
Renalytix (NASDAQ:RNLX) reported its Q3 earnings results on Thursday, June 30, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... 
Via Benzinga
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million. 
Via Benzinga
Renalytix Reports Full Year Fiscal 2022 Results
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
MarketBeat Podcast, 3 Small Caps With Big Upside
Today on The MarketBeat Podcast is Randy Baron, portfolio manager at Pinnacle Associates. Three stocks Randy discusses today have small market capitalizations. 
Via MarketBeat
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million. 
Via Benzinga
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost... 
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
121 Stocks That Hit Their 52-Week Low
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 297 companies achieved new lows for the year. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 250 stocks hit new 52-week lows. 
Via Benzinga
Netflix To $210? Here's The Biggest Price Target Changes For Friday
Piper Sandler cut The Goldman Sachs Group, Inc. (NYSE: GS) price target from $430 to $410. Goldman Sachs shares fell 0.1% to $296.79 in pre-market trading. 
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... 
Via Benzinga
Stocks Eye Dismal Close to Q2, First Half of 2022
The S&P 500 is set to notch its worst first half of the year since 1962, while the Dow and Nasdaq aren't faring much better as they stare at steep losses of their own. 
Via Talk Markets
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For June 30, 2022
Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is expected to report quarterly loss at $0.21 per share on revenue of $152.71 million. 
Via Benzinga
Renalytix AI's Earnings: A Preview
Renalytix AI (NASDAQ:RNLX) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement. Analysts estimate that Renalytix AI... 
Via Benzinga
3 Penny Stocks That Wall Street Thinks Are Undervalued
By and large penny stocks deservedly have a bad rap, but right now selective attention to what Wall Street has to say makes sense for buyers. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
70 Biggest Movers From Friday
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.